Multimodality Risk Adapted Tx Including Induction Chemo for SCCHN Amenable to Transoral Surgery
UNC Lineberger Comprehensive Cancer Center
UNC Lineberger Comprehensive Cancer Center
St. Jude Children's Research Hospital
St. Jude Children's Research Hospital
Hoffmann-La Roche
Hoffmann-La Roche
Alliance Foundation Trials, LLC.
H. Lee Moffitt Cancer Center and Research Institute
Washington University School of Medicine
Wake Forest University Health Sciences
UNC Lineberger Comprehensive Cancer Center
Dana-Farber Cancer Institute
National Institutes of Health Clinical Center (CC)
Washington University School of Medicine
National Institutes of Health Clinical Center (CC)
Alliance for Clinical Trials in Oncology
Alliance for Clinical Trials in Oncology
Bristol-Myers Squibb
Radiation Therapy Oncology Group
M.D. Anderson Cancer Center
Dana-Farber Cancer Institute
University of California, San Francisco
UNC Lineberger Comprehensive Cancer Center
University of Cincinnati
Austrian Breast & Colorectal Cancer Study Group
Hoffmann-La Roche
The University of Texas Health Science Center at San Antonio
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Loma Linda University
Eastern Cooperative Oncology Group
Eastern Cooperative Oncology Group
Hoffmann-La Roche
Genentech, Inc.
Alliance for Clinical Trials in Oncology
CEL-SCI Corporation
Alliance for Clinical Trials in Oncology
Northwestern University
SCRI Development Innovations, LLC
Children's Oncology Group
Columbia University
Children's Oncology Group
Children's Oncology Group
UNC Lineberger Comprehensive Cancer Center
Albert Einstein College of Medicine
Accuray Incorporated
Brown University
Radiation Therapy Oncology Group
M.D. Anderson Cancer Center
The University of Texas Health Science Center at San Antonio